I don't believe so. Bloomberg has posted an article saying that according to a 11/30 letter, Sanofi is "discontinuing " the authorized generic program. They say that the competitive field has changed. Does this not say that Sanofi now believes Momemta will remain the sole generic?
Market Data 
Markets 
AI
